.jpg)
The alternative protein market is exploding. Here's our pick of 7 companies to watch in the next 12 months.
How are strides in the agrigenomics space helping climate and business thrive in 2023? Let’s take a look.
In an ever-changing industry, how can cell and gene therapy start-ups remain dynamic to new challenges to not only survive coming changes but thrive? Click to read more.
The COVID vaccination changed the face of RNA vaccinations and the effect on the oncology market is set to be huge. Click to find out more.
These revolutionary companies are changing the game when it comes to neurological drug development, and thanks to recent funding they could be on the market sooner than you think. Click to find out more.
Pharma packaging is embracing digital health to become smarter and safer. I wanted to highlight some of the exciting developments that are integrating the use of digital technology within the healthcare sectors and the companies involved.
More and more companies are striving to build diverse and inclusive teams. I wanted to speak to an expert at this, who works within the life sciences arena, to find out what they do.
Cytosurge's tiny syringes are a game changer for the single cell genomic and gene editing applications; since patenting the technology in 2009 the company has gone from strength to strength.
A new generation of start-ups are revolutionising cancer diagnosis, detecting disease before patients even show symptoms with liquid biopsy tests. This innovation is rife in the US.
It’s hard to estimate the total size and value of the diagnostics market, however by looking at some of the forecasts available, the scale of the industry is evident.
There’s always a ‘next big thing’ in the healthcare, research and life sciences industries but the emergence and development of the biotech sector is one of the few that has the chance to change the world.
Until very recently, the most talked about and desirable technology within molecular biology was Next Generation Sequencing (NGS). NGS was the technology sales reps wanted to sell and molecular biologists wanted to work with. Recently though,...
The value of the point-of-care (POC) diagnostics market has been steadily increasing for the past 40 years, but we’ve seen exponential growth in the last 2. POC analysis offers several advantages to laboratory-based tests, given that they are norm...
